Informed choice in direct-to-consumer genetic testing (DTCGT) websites: A content analysis of benefits, risks, and limitations

56Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An informed choice about health-related direct-toconsumer genetic testing (DTCGT) requires knowledge of potential benefits, risks, and limitations. To understand the information that potential consumers of DTCGT services are exposed to on company websites, we conducted a content analysis of 23 health-related DTCGT websites. Results revealed that benefit statements outweighed risk and limitation statements 6 to 1. The most frequently described benefits were: 1) disease prevention, 2) consumer education, 3) personalized medical recommendations, and 4) the ability to make health decisions. Thirty-five percent of websites also presented at least one risk of testing. Seventy-eight percent of websites mentioned at least one limitation of testing. Based on this information, potential consumers might get an inaccurate picture of genetic testing which could impact their ability to make an informed decision. Practices that enhance the presentation of balanced information on DTCGT company websites should be encouraged. © National Society of Genetic Counselors, Inc. 2012.

Cite

CITATION STYLE

APA

Singleton, A., Erby, L. H., Foisie, K. V., & Kaphingst, K. A. (2012). Informed choice in direct-to-consumer genetic testing (DTCGT) websites: A content analysis of benefits, risks, and limitations. Journal of Genetic Counseling, 21(3), 433–439. https://doi.org/10.1007/s10897-011-9474-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free